Literature DB >> 35141834

Spread of multidrug-resistant Acinetobacter baumannii isolates belonging to IC1 and IC5 major clones in Rondônia state.

Tiago Barcelos Valiatti1, Tatiane Silva Carvalho2, Fernanda Fernandes Santos3, Carolina Silva Nodari3, Rodrigo Cayô3,4, Juliana Thalita Paulino da Silva3, Cicileia Correia da Silva5, Jacqueline Andrade Ferreira5, Lorena Brandhuber Moura5, Levy Assis Dos Santos5, Ana Cristina Gales3.   

Abstract

In Brazil, carbapenem-resistant A. baumannii (CRAB) is a critical pathogen showing high carbapenem resistance rates. Currently, there is little epidemiological data on A. baumannii isolated in the Northern Brazilian region. Herein, this study aimed to characterize the resistance mechanisms of CRAB isolates recovered from hospitalized patients in the state of Rondônia in 2019. Most of CRAB were considered as extensively drug-resistant, and some of them showed high MICs for minocycline. Only polymyxins showed a satisfactory activity. All isolates carried blaOXA-23 and were included in 14 distinct clusters, with the predominance of clonal group A (29%). The IC1 was the most frequent clonal group, followed by IC5 and IC4. Here, we firstly reported the epidemiological scenario of CRAB in the state of Rondônia, located in the Brazilian Amazon region. The high frequency of CRAB presenting XDR phenotype is of great concern, due to limited therapeutical options, especially in the actual pandemic scenario, in which we observed an overcrowding of ICU beds. Such results are essential to better characterize the epidemiology of CRAB in the entire Brazilian territory.
© 2022. The Author(s) under exclusive licence to Sociedade Brasileira de Microbiologia.

Entities:  

Keywords:  Acinetobacter spp.; Carbapenemase; International clones; Non-fermenter bacilli; Northern region

Mesh:

Substances:

Year:  2022        PMID: 35141834      PMCID: PMC9151963          DOI: 10.1007/s42770-022-00706-4

Source DB:  PubMed          Journal:  Braz J Microbiol        ISSN: 1517-8382            Impact factor:   2.214


  27 in total

1.  OXA-235, a novel class D β-lactamase involved in resistance to carbapenems in Acinetobacter baumannii.

Authors:  Paul G Higgins; Francisco J Pérez-Llarena; Esther Zander; Ana Fernández; Germán Bou; Harald Seifert
Journal:  Antimicrob Agents Chemother       Date:  2013-02-25       Impact factor: 5.191

2.  A new trilocus sequence-based multiplex-PCR to detect major Acinetobacter baumannii clones.

Authors:  Natacha Martins; Renata Cristina Picão; Morgana Cerqueira-Alves; Aline Uehara; Lívia Carvalho Barbosa; Lee W Riley; Beatriz Meurer Moreira
Journal:  Infect Genet Evol       Date:  2016-04-25       Impact factor: 3.342

3.  The changing epidemiology of Acinetobacter spp. producing OXA carbapenemases causing bloodstream infections in Brazil: a BrasNet report.

Authors:  Ana Tereza R Vasconcelos; Afonso L Barth; Alexandre P Zavascki; Ana C Gales; Anna S Levin; Bianca R Lucarevschi; Blenda G Cabral; Danielle M Brasiliense; Flavia Rossi; Guilherme H C Furtado; Irna Carla R S Carneiro; Juliana O da Silva; Julival Ribeiro; Karla V B Lima; Luci Correa; Maria H Britto; Mariama T Silva; Marília L da Conceição; Marina Moreira; Marinês D V Martino; Marise R de Freitas; Maura S Oliveira; Mirian F Dalben; Ricardo D Guzman; Rodrigo Cayô; Rosângela Morais; Sânia A Santos; Willames M B S Martins
Journal:  Diagn Microbiol Infect Dis       Date:  2015-08-12       Impact factor: 2.803

Review 4.  Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages.

Authors:  Raffaele Zarrilli; Spyros Pournaras; Maria Giannouli; Athanassios Tsakris
Journal:  Int J Antimicrob Agents       Date:  2012-11-03       Impact factor: 5.283

5.  Temporal evolution of Acinetobacter baumannii ST107 clone: conversion of blaOXA-143 into blaOXA-231 coupled with mobilization of ISAba1 upstream occAB1.

Authors:  Fernanda Rodrigues-Costa; Rodrigo Cayô; Adriana Pereira Matos; Raquel Girardello; Willames M B S Martins; Floristher Elaine Carrara-Marroni; Ana Cristina Gales
Journal:  Res Microbiol       Date:  2018-07-09       Impact factor: 3.992

6.  Minocycline activity tested against Acinetobacter baumannii complex, Stenotrophomonas maltophilia, and Burkholderia cepacia species complex isolates from a global surveillance program (2013).

Authors:  Robert K Flamm; Mariana Castanheira; Jennifer M Streit; Ronald N Jones
Journal:  Diagn Microbiol Infect Dis       Date:  2016-03-31       Impact factor: 2.803

7.  Global in vitro activity of tigecycline and comparator agents: Tigecycline Evaluation and Surveillance Trial 2004-2013.

Authors:  Daryl J Hoban; Ralf Rene Reinert; Samuel K Bouchillon; Michael J Dowzicky
Journal:  Ann Clin Microbiol Antimicrob       Date:  2015-05-10       Impact factor: 3.944

8.  Molecular characterization and clonal dynamics of nosocomial blaOXA-23 producing XDR Acinetobacter baumannii.

Authors:  Sabrina Royer; Paola Amaral de Campos; Bruna Fuga Araújo; Melina Lorraine Ferreira; Iara Rossi Gonçalves; Deivid William da Fonseca Batistão; Rebecca Tavares E Silva Brígido; Louise Teixeira Cerdeira; Luiz Gustavo Machado; Cristiane Silveira de Brito; Paulo Pinto Gontijo-Filho; Rosineide Marques Ribas
Journal:  PLoS One       Date:  2018-06-11       Impact factor: 3.240

9.  Antimicrobial Susceptibility of Acinetobacter calcoaceticus-Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997-2016).

Authors:  Ana C Gales; Harald Seifert; Deniz Gur; Mariana Castanheira; Ronald N Jones; Helio S Sader
Journal:  Open Forum Infect Dis       Date:  2019-03-15       Impact factor: 3.835

10.  Multidrug-resistant Acinetobacter baumannii clones persist on hospital inanimate surfaces.

Authors:  Igor Vasconcelos Rocha; Danilo Elias Xavier; Karoline Rissele Henrique de Almeida; Sibele Ribeiro de Oliveira; Nilma Cintra Leal
Journal:  Braz J Infect Dis       Date:  2018-09-25       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.